Abstract 11771: Impact of Overweight/Obesity/Higher Body Mass Index on Long-Term Major Adverse Cardiac Outcomes Following Chronic Total Occlusion-Percutaneous Coronary Interventions- A Systematic Review and Meta-Analysis
Rupak Desai,Advait Vasavada,Kshitij Mahajan,ananth vallabh guddeti,Swapnil Surpur,Syed Mohammad Moosi Raza,Mani Chandan Reddy Patlolla,Ehrima Fatima,Zarna Bambhroliya,Paul Gbemudu,Ankit Vyas,Rupak DesaiAdvait VasavadaKshitij Mahajanananth vallabh guddetiSwapnil SurpurSyed Mohammad Moosi RazaMani Chandan Reddy PatlollaEhrima FatimaZarna BambhroliyaPaul GbemuduAnkit VyasIndependent Rscher,Atlanta,GAM.P. Shah Med College,Jamnagar,IndiaGovernment Med College,PatialaMediciti Institute of Med Sciences,HyderabadJawaharlal Nehru medical college,BelagaviFortis Escorts Heart Institute,New DelhiKamineni Institute of Med Sciences,IndiaDow Med College,KarachiTianjin Med UnivThomas Jefferson Univ,Wilmington,DEBaptist Hosp of Southeast Texas,Beaumont,TX
DOI: https://doi.org/10.1161/circ.146.suppl_1.11771
IF: 37.8
2022-11-01
Circulation
Abstract:Circulation, Volume 146, Issue Suppl_1, Page A11771-A11771, November 8, 2022. Background:Obesity is usually associated with worse cardiovascular outcomes. However, fewer studies have evaluated its impact on long-term major adverse cardiovascular events (MACE) following CTO PCI. We conducted a meta-analysis to assess the same.Methods:PUBMED, Scopus, and EMBASE were systematically searched for studies reporting long-term (at least >1 year) outcomes with obesity vs no obesity in patients with CTO PCI. MACE events [all-cause mortality, cardiac mortality, revascularization, restenosis/reocclusion, recurrent angina pectoris (RAP), target-vessel myocardial infarction (MI), heart failure, cardiac death, or ischemia-driven target-vessel revascularization (TVR) were the primary endpoint. Pooled odds ratios (OR) and heterogeneity were assessed with random-effects models and I2 statistics respectively. Subgroup analysis was performed to assess the risk by age group and follow-up duration. The leave-one-study-out method was used for sensitivity analysis.Results:After an initial electronic search of thirty-two studies, five studies were selected, and between 2016 to 2021 selected were included in the final analysis. The sample size consisted of 5022 patients with a median age of 63. No significant impact of higher BMI/obesity was seen overall on a median duration of 2.6 yrs [OR(95% CI)= 0.95 (0.82-1.11), p=0.53, I2= 90.86%)](Fig 1).However, on a subgroup analysis, the geriatric age group (≥65 yrs) demonstrated an "Obesity Paradox" effect on MACE after CTO PCI, [OR (95%CI)=0.64 (0.47-0.88), I2=42.13, p<0.01]. There was no difference in a subgroup analysis based on follow-up duration (≥3 years [OR (95%CI)=0.73 (0.42-1.27)] vs <3 years OR (95%CI)=1.04 (0.84-1.27)].Conclusions:Although higher BMI/obesity was not associated with overall long-term MACE in CTO PCI, the subgroup analysis demonstrated the "Obesity Paradox" (protective) effect in studies with a predominantly geriatric population.
cardiac & cardiovascular systems,peripheral vascular disease